Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Editorial

Published on 11 Dec 2024

Editorial: Peptides against infectious diseases: from antimicrobial peptides to vaccines

in Pharmacology of Infectious Diseases

Joanna Bojarska
Xiumin Wang
Mariusz Skwarczynski

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1522148

1,038 views

Review

Published on 06 Dec 2024

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring

in Pharmacology of Infectious Diseases

Li Jiang
Zhiqiang Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439586

3,117 views
2 citations

Original Research

Published on 05 Dec 2024

Impact on parasitemia, survival time and pro-inflammatory immune response in mice infected with Plasmodium berghei treated with Eleutherine plicata

in Pharmacology of Infectious Diseases

Antônio Rafael Quadros Gomes
Ana Laura Gadelha Castro
Gleison Gonçalves Ferreira
Heliton Patrick Cordovil Brígido
Everton Luiz Pompeu Varela
Valdicley Vieira Vale
Liliane Almeida Carneiro
Maria Fâni Dolabela
Sandro Percario

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484934

1,126 views

Original Research

Published on 04 Dec 2024

Signal detection and analysis of adverse events associated with Genvoya® based the FAERS database

in Pharmacology of Infectious Diseases

Chengliang Wang
Yan Zhang
Xiting Tang
Guoping Zhang
Li Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439781

1,985 views

Review

Published on 20 Nov 2024

Natural compounds in the fight against Staphylococcus aureus biofilms: a review of antibiofilm strategies

in Pharmacology of Infectious Diseases

Milad Kashi
Milad Noei
Zahra Chegini
Aref Shariati

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491363

4,653 views
7 citations

Original Research

Published on 18 Nov 2024

Comparative bactericidal activity of four macrolides alone and combined with rifampicin or doxycycline against Rhodococcus equi at concentrations achievable in foals

in Pharmacology of Infectious Diseases

Anne-Sophie Huguet
Ophélie Gourbeyre
Agathe Bernand
Charline Philibert
Alain Bousquet-Melou
Elodie A. Lallemand
Aude A. Ferran

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1458496

1,597 views

Original Research

Published on 15 Nov 2024

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV

in Pharmacology of Infectious Diseases

Paul Thoueille
Susana Alves Saldanha
Fabian Schaller
Eva Choong
François Veuve
Aline Munting
Matthias Cavassini
Dominique Braun
Huldrych F. Günthard
Jessy J. Duran Ramirez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437400

2,119 views

Original Research

Published on 13 Nov 2024

Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Hui-Bin Huang
Yi-Bing Zhu
Da-Xing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422490

1,948 views

Correction

Published on 06 Nov 2024

Corrigendum: ArboItaly: leveraging open data for enhanced arbovirus surveillance in Italy

in Pharmacology of Infectious Diseases

Francesco Branda
Marta Giovanetti
Giancarlo Ceccarelli
Massimo Ciccozzi
Fabio Scarpa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517547

697 views

Review

Published on 06 Nov 2024

COVID-19 vaccines: current and future challenges

in Pharmacology of Infectious Diseases

Davood Mohammadi
Matin Ghasemi
Nahid Manouchehrian
Milad Zafarmand
Mitra Akbari
Amir Bahador Boroumand

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1434181

3,147 views
1 citation

Clinical Trial

Published on 06 Nov 2024

Investigation on improving immunologic reconstitution insufficiency using DiwuYanggan capsules in AIDS patients

in Pharmacology of Infectious Diseases

Jing Wen Ke
Yao Chen
En Ze Lei
Ming Zhong Xiao
Wei Ni
Fang Huang
Han Min Li
Hong Lin Jiang
Lian Guo Ruan
Jian Zhong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485719

1,050 views

Original Research

Published on 05 Nov 2024

Thanatin and vinyl sulfide analogues as narrow spectrum antimicrobial peptides that synergise with polymyxin B

in Pharmacology of Infectious Diseases

Oscar A. Shepperson
Paul W. R. Harris
Margaret A. Brimble
Alan J. Cameron

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487338

1,549 views
2 citations

Original Research

Published on 05 Nov 2024

Development of prediction models for carbapenem-resistant Klebsiella pneumoniae acquisition and prognosis in adult patients

in Pharmacology of Infectious Diseases

Huijuan Yao
Yu Yang
Huimin Yao
Shuhong Bu
Lixia Li
Fang Wang
Jian Zhang
Jihui Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439116

1,263 views
1 citation

Systematic Review

Published on 31 Oct 2024

The efficacy and safety of addition of pegylated interferon to long-term nucleos(t)ide analogue therapy on functional cure of chronic hepatitis B patient: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Xu Zhang
Xianzhao Yang
Lingjie Tan
Yujia Tian
Zhiren Zhao
Shuying Ru

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474342

2,045 views
1 citation

Brief Research Report

Published on 30 Oct 2024

First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion

in Pharmacology of Infectious Diseases

Paul Laffont-Lozes
Tayma Naciri
Alix Pantel
Aurélie Martin
Anne-Sophie Pruvot-Occean
Vincent Haignere
Paul Loubet
Albert Sotto
Romaric Larcher

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347306

1,507 views
3 citations

Brief Research Report

Published on 28 Oct 2024

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study

in Pharmacology of Infectious Diseases

Rubén Martín-Escolano
Ana Virseda-Berdices
Juan Berenguer
Juan González-García
Oscar Brochado-Kith
Amanda Fernández-Rodríguez
Cristina Díez
Victor Hontañon
The Marathon Study Group
Salvador Resino

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341612

1,174 views
1 citation